Kaneko Hiroki, Terasaki Hiroko
Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya Japan.
Transl Vis Sci Technol. 2017 Jul 10;6(4):5. doi: 10.1167/tvst.6.4.5. eCollection 2017 Jul.
Even with a high surgical success rate for retinal detachment and proliferative vitreoretinopathy (PVR) supported by the robust improvement in vitrectomy surgery and its related devices, certain questions still remain for the pathogenesis and treatment of PVR. One of the important biological events in PVR is epithelial-mesenchymal transition (EMT) of the retinal pigment epithelial (RPE) cells. MicroRNAs are noncoding, small, single-strand RNAs that posttranscriptionally regulate gene expression and have essential roles in homeostasis and pathogenesis in many diseases. Recently, microRNAs also had a critical role in EMT in many tissues and cells. One main purpose of this brief review is to describe the knowledge obtained from microRNA research, especially concerning vitreoretinal diseases. In addition, the potential role of microRNAs in prevention of PVR by regulating EMT in RPE cells is described. Understanding microRNA involvement in PVR could be helpful for developing new biological markers or therapeutic targets and reducing the rate of visual disability due to PVR.
尽管玻璃体切除术及其相关设备的显著改进使得视网膜脱离和增生性玻璃体视网膜病变(PVR)的手术成功率很高,但PVR的发病机制和治疗仍存在一些问题。PVR的重要生物学事件之一是视网膜色素上皮(RPE)细胞的上皮-间质转化(EMT)。微小RNA是一类非编码的小单链RNA,可在转录后调节基因表达,在许多疾病的稳态和发病机制中发挥重要作用。最近,微小RNA在许多组织和细胞的EMT中也起着关键作用。本简要综述的一个主要目的是描述从微小RNA研究中获得的知识,特别是关于玻璃体视网膜疾病的知识。此外,还描述了微小RNA通过调节RPE细胞中的EMT在预防PVR中的潜在作用。了解微小RNA与PVR的关系可能有助于开发新的生物标志物或治疗靶点,并降低PVR导致的视力残疾率。